I-7-Fluoro-6-Nitroquinazolin-4 (1H)-enye i-CAS 162012-69-3 Ucoceko > 99.0% (HPLC) I-Afatinib Dimaleate Intermediate Factory

Inkcazelo emfutshane:

Igama leKhemikhali: 7-Fluoro-6-Nitroquinazolin-4 (1H) -enye

CAS: 162012-69-3

Ubunyulu: >99.0% (HPLC)

Mthubi ukuya kuBomvu iCrystal etyheli okanye uPowder

Phakathi kwe-Afatinib Dimaleate (CAS: 850140-73-7)

Umgangatho ophezulu, iMveliso yoRhwebo

E-Mail: alvin@ruifuchem.com


Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Iipropati zeMichiza:

Igama leMchiza 7-Fluoro-6-Nitroquinazolin-4 (1H)-enye
Izithethantonye I-7-Fluoro-6-Nitroquinazolin-4 (3H) -enye;I-7-Fluoro-4-Hydroxy-6-Nitroquinazoline;7-Fluoro-6-Nitroquinazolin-4-ol;I-7-Fluoro-6-Nitro-4-Hydroxyquinazoline;7-Fluoro-6-Nitro-1H-Quinazolin-4-enye
Inombolo yeCAS 162012-69-3
Inombolo yeCAT RF-PI2025
Ubume beStokhwe Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli C8H4FN3O3
Ubunzima beMolekyuli 209.13
Uphawu Ruifu Chemical

Iinkcukacha:

Into Iinkcukacha
Imbonakalo Mthubi ukuya kuBomvu iCrystal etyheli okanye uPowder
I-1 H NMR Spectrum Ukungqinelana Nolwakhiwo
Ubunyulu / Indlela yokuHlalutya >99.0% (HPLC)
Ilahleko ekomisweni <0.50%
Ukungcola ngokupheleleyo <1.00%
Proton NMR Spectrum Iyahambelana neSakhiwo
Umgangatho woVavanyo Umgangatho woShishino
Ukusetyenziswa Phakathi kwe-Afatinib Dimaleate (CAS: 850140-73-7)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

1

FAQ:

Isicelo:

I-7-Fluoro-6-Nitroquinazolin-4 (1H)-enye (i-CAS: 162012-69-3) iphakathi kwe-Afatinib Dimaleate (CAS: 850140-73-7).I-Afatinib lusapho lwe-ErbB olungajikiyo lwezithinteli ezicinezela usasazo lolwazi kunye nokuthintela iindlela eziphambili ezibandakanyekayo ekukhuleni kweeseli zomhlaza kunye nokwahlukana.Ngenxa yokuba i-ErbB yolwazi lwentsapho i-transduction indlela yokudlulisa ulwazi inokuthi iqhutywe ngama-homodimers amaninzi kunye ne-heterodimers, ukuvinjelwa kwangaxeshanye kwamalungu amaninzi osapho lwe-ErbB (njenge-EGFR, i-HER2, i-ErbB3 kunye ne-ErbB4) inokuphazamisa ngokufanelekileyo ukuhanjiswa kolwazi olusezantsi.I-Afatinib lichiza elivunyiweyo kunyango lwe-non-small cell lung carcinoma(NSCLC), ephuhliswe ngu-Boehringer Ingelheim.Isebenza njenge-angiokinase inhibitor.Njenge-lapatinib kunye ne-neratinib, i-afatinib yi-tyrosine kinase inhibitor (TKI) ephinda ivimbele ngokungenakuguquleka i-epidermal growth factor receptor 2 (Her2) kunye ne-epidermal growth factor receptor (EGFR) kinases.I-Afatinib ayisebenzi kuphela ngokuchasene nokuguqulwa kwe-EGFR ekujoliswe kuyo kwisizukulwana sokuqala se-TKIs likeerlotinib okanye i-gefitinib, kodwa nakwabo bangenaluvelwano kolu nyango luqhelekileyo.Ngenxa yomsebenzi wayo owongezelelweyo ngokuchasene ne-Her2, iphandwa umhlaza wamabele kunye neminye imihlaza eqhutywa yi-EGFR kunye ne-Her2.

Bhala umyalezo wakho apha kwaye uwuthumele kuthi